%0 Generic
%A Hernando, J.
%A Manzano, J. L.
%A Teule, A.
%A Lopez, C.
%A Garcia-Carbonero, R.
%A Benavent Vinuales, M.
%A Custodio, A.
%A Cubillo, A.
%A Alonso, V.
%A Alonso-Gordoa, T.
%A Carmona-Bayonas, A.
%A Crespo, G.
%A Blanco, M.
%A Jimenez-Fonseca, P.
%A Viudez, A.
%A La Casta, A.
%A Sevilla, I.
%A Llanos, M.
%A Segura, A.
%A Capdevila, J.
%T Durvalumab plus tremelimumab influence on response to subsequent treatments in patients with neuroendocrine neoplasms (NENs) of gastroenteropancreatic and lung origins: Results from the phase II DUNE trial (GETNE 1601)
%D 2021
%@ 0923-7534
%U https://hdl.handle.net/10668/27027
%~